REG - Graft Polymer (UK) - Notice of AGM

Graft Polymer (UK)Announcement

04/06/2024 16:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240604:nRSD1025Ra&default-theme=true

RNS Number : 1025R  Graft Polymer (UK) PLC  04 June 2024

  

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF
EU REGULATION 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM
BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE
INFORMATION WILL BE CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

4th June 2024

 

Graft Polymer (UK) Plc

(the "Company")

 

AGM Notice

 

The Company announces that the notice of the Company's Annual General Meeting
(the "AGM Notice") and proxy form have today been posted to shareholders and
can be found on the Company's website:
https://graftpolymer.com/investor-relations/
(https://graftpolymer.com/investor-relations/) .

 

The Annual General Meeting will take place at 12.30pm on 28th June 2024 at the
Company's registered office, 25 Eccleston Place, London SW1W 9NF.

 

Shareholders wishing to attend are kindly requested to contact the Company's
chairman, Nicholas Nelson (details below), no later than 48 hours in advance
of the meeting.

 

As detailed in the Company's announcement of its final results for the year
ended 31 December 2023 on 30 April 2024, the Board's principal task is to
conduct an equity fundraise in the near future for working capital purposes
and for the development of its modified business development strategy. The AGM
Notice includes resolutions seeking authority to allow the directors to allot
ordinary shares on a non-pre-emptive basis which,  should they be passed,
would provide the Directors with the flexibility to issue shares in relation
to an equity fundraise, amongst other matters.

 

Any equity fundraise would also require the publication of a Financial Conduct
Authority approved prospectus by the Company to enable new shares to be
admitted to trading on the Main Market of the London Stock Exchange. Further
announcements will be made as appropriate regarding this matter.

 

Enquiries:

 

Graft Polymer (UK) Plc

Nicholas Nelson, Non-Executive Chairman

nelson@nexfin.org.uk

 

Allenby Capital (Broker)

Nick Naylor / Liz Kirchner (Corporate Finance)

Guy McDougall (Sales)

 +44 (0) 20 3328 5656

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAUSUVRSVUNRAR